Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grimwade

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|May 8, 1999
Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working PartyS Allford, D Grimwade, S Langabeer, et al.
Leukemia|April 16, 2011
Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNetM Østergaard, C G Nyvold, J V Jovanovic, et al.
Leukemia|November 7, 2008
The molecular anatomy of the FIP1L1-PDGFRA fusion geneC Walz, J Score, J Mix, et al.
Blood|August 15, 2000
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangementsD Sainty, V Liso, A Cantù-Rajnoldi, et al.
Blood|August 15, 2000
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"D Grimwade, A Biondi, M J Mozziconacci, et al.
Leukemia|December 11, 2012
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasiaC Craddock, L Quek, N Goardon, et al.
Leukemia|October 17, 2003
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer programJ Gabert, E Beillard, V H J van der Velden, et al.
Haematologica|June 22, 2001
Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocolsP Bolufer, F Lo Coco, D Grimwade, et al.
Leukemia|January 29, 2015
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNetE Lengfelder, F Lo-Coco, L Ades, et al.
Leukemia|May 4, 2007
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurementsJ Saldanha, M Silvy, N Beaufils, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|May 8, 1999
Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working PartyS Allford, D Grimwade, S Langabeer, et al.
Leukemia|April 16, 2011
Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNetM Østergaard, C G Nyvold, J V Jovanovic, et al.
Leukemia|November 7, 2008
The molecular anatomy of the FIP1L1-PDGFRA fusion geneC Walz, J Score, J Mix, et al.
Blood|August 15, 2000
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangementsD Sainty, V Liso, A Cantù-Rajnoldi, et al.
Blood|August 15, 2000
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"D Grimwade, A Biondi, M J Mozziconacci, et al.
Leukemia|December 11, 2012
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasiaC Craddock, L Quek, N Goardon, et al.
Leukemia|October 17, 2003
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer programJ Gabert, E Beillard, V H J van der Velden, et al.
Haematologica|June 22, 2001
Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocolsP Bolufer, F Lo Coco, D Grimwade, et al.
Leukemia|January 29, 2015
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNetE Lengfelder, F Lo-Coco, L Ades, et al.
Leukemia|May 4, 2007
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurementsJ Saldanha, M Silvy, N Beaufils, et al.
Pageof 5